COVID-19 may have a mild course in the immunocompromised children
Researchers from 25 countries responded to a flash survey on the current incidence and severity of COVID-19 among children who receive anti-cancer chemotherapy, organized by doc. Ondřej Hrušák from the Second Faculty of Medicine and his colleagues.